Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

UROMITEXAN INJECTION 400MG/4ML - HSA Drug Approval Details

Approvals/HSA/UROMITEXAN INJECTION 400MG/4ML

Approved

THERAPEUTIC

UROMITEXAN INJECTION 400MG/4ML

BAXTER ONCOLOGY GMBH (GERMANY)🇸🇬 Health Sciences Authority

Approval Date: Apr 8, 1991
Approval ID: b8e2c7041a50f1c7
Company: BAXTER ONCOLOGY GMBH (GERMANY)
Type: Therapeutic

Approval Details

Approval Id: b8e2c7041a50f1c7
Drug Name: UROMITEXAN INJECTION 400MG/4ML
Product Name: UROMITEXAN INJECTION 400MG/4ML
Approval Number: SIN05694P
Approval Date: 1991-04-08
Registrant: BAXTER HEALTHCARE (ASIA) PTE LTD
Licence Holder: BAXTER HEALTHCARE (ASIA) PTE LTD
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: INJECTION
Route Of Administration: INTRAVENOUS
Atc Code: V03AF01
Atc Item Name: mesna
Pharma Manufacturer Name: BAXTER HEALTHCARE (ASIA) PTE LTD
Company Detail Path: /organization/baxter-healthcare-asia-pte-ltd

Active Ingredients

MESNA

100.0 mg/ml

MESNA

100 MG/ML

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Apr 8, 1991

Approval ID

b8e2c7041a50f1c7

Type

Therapeutic

Back to HSA Approvals